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Abstract
Aims: Portal hypertension characterized by generalized vasodilatation with endothelial dysfunction affecting nitric oxide
(NO) and endothelium-dependent hyperpolarization (EDH) has been suggested to involve bacterial translocation and/or the
angiotensin system. The possibility that ingestion of probiotics prevents endothelial dysfunction in rats following common
bile duct ligation (CBDL) was evaluated.
Methods: Rats received either control drinking water or the probiotic VSL#3 solution (50 billion bacteria.kg body
wt21.day21) for 7 weeks. After 3 weeks, rats underwent surgery with either resection of the common bile duct or sham
surgery. The reactivity of mesenteric artery rings was assessed in organ chambers, expression of proteins by
immunofluorescence and Western blot analysis, oxidative stress using dihydroethidium, and plasma pro-inflammatory
cytokine levels by flow cytometry.
Results: Both NO- and EDH-mediated relaxations to acetylcholine were reduced in the CBDL group compared to the sham
group, and associated with a reduced expression of Cx37, Cx40, Cx43, IKCa and SKCa and an increased expression of
endothelial NO synthase (eNOS). In aortic sections, increased expression of NADPH oxidase subunits, angiotensin converting
enzyme, AT1 receptors and angiotensin II, and formation of ROS and peroxynitrite were observed. VSL#3 prevented the
deleterious effect of CBDL on EDH-mediated relaxations, vascular expression of connexins, IKCa, SKCa and eNOS, oxidative
stress, and the angiotensin system. VSL#3 prevented the CBDL-induced increased plasma TNF-a, IL-1a and MCP-1 levels.
Conclusions: These findings indicate that VSL#3 ingestion prevents endothelial dysfunction in the mesenteric artery of
CBDL rats, and this effect is associated with an improved vascular oxidative stress most likely by reducing bacterial
translocation and the local angiotensin system.
Citation: Rashid SK, Khodja NI, Auger C, Alhosin M, Boehm N, et al. (2014) Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension:
Role of the Angiotensin System. PLoS ONE 9(5): e97458. doi:10.1371/journal.pone.0097458
Editor: Concepcio´n Peiro´, Facultad de Medicina, Universidad Autonoma Madrid, Spain
Received November 8, 2013; Accepted April 21, 2014; Published May 15, 2014
Copyright:  2014 Rashid et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was supported by an unrestricted research grant from Actial Farmaceutica Lda (Funchal, Madeira). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The study has been supported by an unrestricted funding support from a commercial source (Actial Farmaceutica Lda), which has been
used exclusively to cover the animal expenses, pharmacological reagents, molecular biology and immunofluorescence analyses. No author has any relationship
with the commercial funder such as employment, consultancy, patents, products in development, and marketed products. This financial support does not alter
the authors’ adherence to PLOS ONE policies on sharing data and materials.
* E-mail: valerie.schini-kerth@unistra.fr (VBSK); monique.oswald@chru-strasbourg.fr (MOM)
Introduction
Advanced chronic liver diseases are characterized by general-
ized progressive vasodilatation, related to portal hypertension
(PH), which is especially observed in the splanchnic and
pulmonary beds. In a rat model of partial portal vein ligation,
Albrades et al. [1] reported that the initial event in response to PH
is an up-regulation of vascular endothelial growth factor and
endothelial nitric oxide synthase (eNOS) in the intestinal
microcirculation. Although animal models have led to a number
of hypotheses, the exact mechanism involved in the occurrence of
the generalized vasodilatation and hyperdynamic syndrome is
incompletely understood [2–5]. Several lines of evidence support a
role for an increased formation of nitric oxide (NO) in the general
vasodilatation in chronic liver diseases in patients [6] and also in
the chronic bile duct ligated (CBDL) rat model [2,4]. In addition,
chronic liver diseases in patients and also in experimental PH are
characterized by an increased vascular formation of reactive
oxygen species (ROS) [7,8] and the activation of the renal renin-
angiotensin-aldosterone system and the local angiotensin system
[9–11]. Moreover, it has been suggested that bacterial transloca-
tion (BT) is an important step in the occurrence of the general
vasodilatation and especially in the pulmonary bed [3,12]. In
cirrhosis, BT is defined as the migration of bacteria and/or their
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products from the intestinal lumen to mesenteric lymph nodes [13]
as a consequence of intestinal bacterial overgrowth, impaired host
defenses, and/or disruption of the gut mucosal barrier [14,15]. In
cirrhotic rats, BT has been reported to lead to endotoxaemia,
which stimulates the expression of TNF-a leading to an enhanced
formation of the potent vasodilators NO and carbon monoxide
[3]. Thus, reducing BT to improve the excessive oxidative stress
and/or to reduce the increased vasodilator factors is an interesting
target to improve the general vascular dysfunction in PH. Earlier
studies have reported that treatment with either antiobiotics or
pentoxifylline, an inhibitor of TNF-a, to prevent BT and/or its
consequences improves the vasodilatation in CBDL rats [12,16]
and also in patients with liver cirrhosis [17,18]. Due to the poor
tolerance of pentoxifylline [18] and the increased risk of bacterial
resistance with antibiotics, probiotics such as VSL#3 which are
well tolerated [19,20] may be of interest. Thus, the aim of the
present study was to evaluate the effect of the probiotic VSL#3
formulation on the vascular dysfunction in an animal model of
biliary cirrhosis with PH with a special attention to oxidative stress
and the local angiotensin system.
Materials and Methods
Ethics statement
This study conforms to the Guide of Care and the Use of
laboratory Animals published by the US National Institutes of
Health (NIH publication No. 85–23, revised 1996). The present
protocol was approved by the local Ethics Committee (Comite´
Re´gional d’Ethique en Matie`re d’Expe´rimentation Animale,
approval AL/01/09/09/05).
Animal model
Male Wistar rats (10–12 week-old) were anaesthetized with an
intraperitoneal mixture of ketamine (80 mg.kg body wt21) and
xylazine (4 mg.kg body wt21). Biliary cirrhosis was induced by
CBDL. After laparotomy, the bile duct was isolated, double ligated
and resected between the two ligatures. Sham rats had laparot-
omy, underwent mobilization of the common bile duct without
ligation. After surgery, rats were housed in a thermo-neutral
environment, on a 12:12 h photoperiod and were provided food
and drinking water at libitum. Eight CBDL rats and seven sham
rats were treated three weeks before and 4 weeks following surgery
with the probiotic formulation VSL#3 (VSL Pharmaceuticals,
Inc, Towson, MD, USA; Streptococcus thermophilus, Bifidobacterium
longum, Bifidobacterium breve, Bifidobacterium infantis, Lactobacillus
acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus
bulgaricus) at a dose of 50 billion bacteria.kg body wt21 daily,
given in the drinking water. Seven CBDL rats and five sham rats
receiving vehicle served as controls.
Four weeks after surgery, rats were sacrificed. The liver and
spleen were removed and weighted. Liver samples (taken from the
median lobe) from each rat were incubated in the Bouin-Holland
fixative and subsequently embedded in paraffin for histological
analysis. Segments of the main superior mesenteric artery and
thoracic aorta were cleaned, embedded in Tissu-Tek O.C.T.
compound (Sakura Finetek France SAS, Villeneuve d’Ascq,
France) and snap-frozen for immunofluorescence studies and the
determination of the formation of ROS. Samples of blood were
taken by heart puncture, and, thereafter, plasma was stored at
-80uC for subsequent serological analysis.
Assessment of liver cirrhosis and portal hypertension
Sections of liver samples (5 mm thick) were stained with
hematoxylin, eosin and Masson’s trichrome stain and evaluated
by light microscopy. Histologically, liver of chronic bile duct
ligation showed evidence of intrahepatic tubular duct hypertrophy
with severe fibrosis. Portal hypertension is reflected by an increase
in the spleen weight.
Vascular reactivity studies
Vascular reactivity studies on the main superior mesenteric
artery were performed as described previously [11]. Briefly, the
main superior mesenteric artery was cleaned of connective tissue,
cut into rings (2–3 mm in length) and suspended in organ baths
containing oxygenated Krebs bicarbonate solution for the
determination of changes in isometric tension. After equilibration
and functional tests, rings were contracted with phenylephrine
(PE, 1 mM) before construction of concentration-response curves
in response to acetylcholine (ACh), sodium nitroprusside or
levcromakalim. In some experiments, rings were exposed to an
inhibitor for 30 min before contraction with PE. Relaxations were
expressed as percentage of the contraction induced by PE.
Immunofluorescence studies
Frozen arteries were cryosectioned at 14 mm. Sections were air-
dried for 15 min and stored at 280uC until use. Sections were first
fixed with paraformaldehyde at 4%, washed and treated with 10%
milk or 5% goat serum in PBS containing 0.1% Triton X-100 for
1 h at room temperature to block non-specific binding. Mesenteric
artery sections were then incubated overnight at 4uC with an
antibody directed against either eNOS (1/100), small and
intermediate conductance calcium-activated potassium channels
(SKCa, IKCa, 1/200), or connexins (Cx37, Cx40 and Cx43; 1/100
to 1/200). Aortic sections were incubated with an antibody
directed against either angiotensin II (1/500), AT1 receptors (1/
400), angiotensin-converting enzyme (ACE, 1/200), nitrotyrosine
(1/200), p47phox (1/200), p22phox (1/200) or cyclooxygenase-1
or -2 (COX-1, COX-2, 1/200). Sections were then washed with
PBS, incubated with the secondary antibody (1/300, Alexa 488- or
637-conjugated goat anti-rabbit IgG) for 2 h at room temperature
in the dark before being washed with PBS and mounted in Dako
fluorescence mounting medium (Dako France SAS, Les Ulis,
France) and cover-slipped. For negative controls, primary
antibodies were omitted.
Western blot analysis
Mesenteric artery and aortic segments were homogenized in
extraction buffer (composition in mM: Tris/HCl 20 (pH 7.5; Q
Biogene), NaCl 150, Na3VO4 1, sodium pyrophosphate 10, NaF
20, okadaic acid 0.01 (Sigma), a tablet of protease inhibitor
(Complete Roche) and 1% Triton X-100 (Euromedex)). Total
proteins (10 mg) were separated on SDS-polyacrylamide gels and
transferred electrophoretically onto polyvinylidine difluoride
membranes (Amersham). Membranes were blocked with blocking
buffer containing 5% bovine serum albumin, Tris-buffered saline
solution (Biorad) and 0.1% Tween 20 (Sigma) (TBS-T) for 1 h.
Membranes were then incubated overnight at 4uC with an
antibody directed against either eNOS (1/10000), SKCa (1/200),
AT1 receptors (1/1000), p47phox (1/1000), p22phox (1/1000) or
COX-2, (1/1000). Thereafter, membranes were incubated with an
appropriate horseradish peroxidase-conjugated secondary anti-
body and signals were detected using enhanced chemilumines-
cence (Amersham).
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Determination of vascular and mitochondrial ROS
Formation
In situ formation of ROS was performed using the method
previously described [21]. The redox-sensitive fluorescent dye
dihydroethidium (DHE, 2.5 mM) was applied onto 25 mm unfixed
cryosections of aorta for 30 min at 37uC in a light-protected
humidified chamber. To determine the sources of ROS, sections
were incubated with either apocynin (NADPH oxidase inhibitor
and antioxidant, 300 mM), L-NA (NO synthase inhibitor,
300 mM), sulfaphenazol (cytochrome P450 inhibitor, 100 mM),
indomethacin (cyclooxygenase inhibitor, 10 mM) or inhibitors of
the mitochondrial respiration chain (myxothiazol, 0.5 mM+rote-
none, 1 mM+KCN, 1 mM) for 30 min at 37uC before the addition
of dihydroethidium. The in situ formation of mitochondrial ROS
was performed using MitoSox (Life Technologies SAS, Saint
Aubin, France), a mitochondrion-specific dihydroethidium-deriv-
ative fluorescent dye. Briefly, 14 mm unfixed cryosections of aorta
were incubated with MitoSox (5 mM at 37uC for 60 min) in a
light-protected humidified chamber. Sections were then washed
three times, mounted in DAKO and cover-slipped.
Image analysis
All samples from immunofluorescence and in situ ROS
formation studies were observed using a confocal laser-scanning
microscope (Leica SP2 UV DM IRBE). Quantification of
fluorescence levels was performed using FIJI GPL v2 software
(http://fiji.sc/Fiji).
Determination of plasma inflammatory cytokine levels
The determination of the plasma level of TNF-a, IL-1a, MCP-1
and IL-4 was performed using a commercial rat cytokine Kit
Flowcytomix (eBioscience SAS, Paris, France), multiple analyte
detection kit, according to the protocol supplied by the manufac-
turer. The raw data were analysed using ‘‘The FlowCytomixPro
software’’.
Statistical analysis
Values are expressed as means 6 SEM. Statistical analysis was
performed using either Student’s t test or an analysis of variance
(ANOVA) followed by the Bonferroni post-hoc test as appropriate
using GraphPad Prism (version 5 for Microsoft windows,
GraphPad software, Inc, San Diego, CA, USA). A P value less
than 0.05 was considered to be statistically significant.
Results
Characteristics and histologic findings
As shown in Table 1, four weeks after surgery, CBDL rats had a
significantly increased spleen weight, and an enhanced bile duct
proliferation as assessed by histological analysis of liver sections.
Chronic intake of VSL#3 for seven weeks starting three weeks
before the surgery reduced slightly but significantly the CBDL-
induced increase in spleen weight whereas the liver weight was
unaffected. The VSL#3 treatment alone had no effect on liver
and spleen weight.
VSL#3 treatment prevents the CBDL-induced impaired
EDH but not NO component of the relaxation to
acetylcholine in mesenteric artery rings
ACh caused similar concentration-dependent relaxations in
mesenteric artery rings from control and CBDL rats (maximal
relaxations amounted to 97.461.4% and 94.962.4%, respective-
ly, n = 6–8). However, the NO component of the relaxation as
assessed in the presence of indomethacin and charybdotoxin plus
apamin to prevent the formation of vasoactive prostanoids and
EDH, respectively, was significantly impaired in the CBDL group
(Figure 1A). In addition, the EDH-mediated component of the
relaxation as assessed in the presence of indomethacin plus NG-
nitro-L-arginine (an inhibitor of eNOS), was also significantly
reduced in the CBDL group (Figure 1B). Although the VSL#3
treatment did not affect the CBDL-induced impaired NO
component, it significantly improved the EDH component
(Figures 1A and B). In addition, both the sodium nitroprusside
(an NO donor) and the levcromakalim (an ATP-sensitive K
channel opener) induced endothelium-independent relaxations
were similar in all groups (Figures 1C and D).
VSL#3 treatment prevents CBDL-induced up-regulation
of eNOS and down-regulation of SKCa, IKCa, Cx37, Cx40,
and Cx43 in the mesenteric artery
Immunofluorescence studies indicated that the eNOS signal is
observed predominantly at the luminal surface of mesenteric
artery sections in the control group, and that this signal is
significantly increased in the CBDL group (Figure 2A). Pro-
nounced fluorescence signals for SKCa and IKCa, two calcium-
activated potassium channels involved in EDH [11], are observed
throughout the arterial wall in the control group whereas both
signals are significantly reduced in the CBDL group (Figure 2A).
In addition, the fluorescence signal of connexins Cx37, Cx40 and
Cx43, which form myoendothelial gap junctions transmitting the
hyperpolarization from endothelial cells to the underlying smooth
muscle cells to cause relaxation [11], is observed predominantly at
the luminal surface and also to some extent in the vascular smooth
muscle (Figure 2B). The fluorescence signals of Cx37, Cx40 and
Cx43 are significantly reduced in the CBDL group (Figure 2B).
The VSL#3 treatment prevented partially but significantly the
CBDL-induced up-regulation of eNOS, and the down-regulation
of SKCa and IKCa, and of Cx37, Cx40 and Cx43 (Figure 2). The
VSL#3 treatment of sham rats was without effect except for
SKCa, which was significantly reduced (Figure 2). An increased
eNOS protein level and a decreased SKCa level were also observed
in the CBDL group as assessed by Western blot analysis
(Figure 2C). These effects were significantly prevented by the
VSL#3 treatment (Figure 2C). In addition, IKCa and Cx37
protein levels were below the detection level in all groups.
VSL#3 treatment reduces the CBDL-induced vascular
oxidative stress involving several sources in the aorta
CBDL markedly increased the DHE fluorescence signal, the
MitoSOX fluorescence signal and the nitrotyrosine fluorescence
signal throughout the aortic wall, and the eNOS fluorescence
signal at the luminal surface and eNOS protein level as assessed by
Western blot analysis (Figures 3A and 4B). All these effects were
significantly prevented by the ingestion of VSL#3 (Figures 3A and
4B). The VSL#3 treatment of sham rats affected only minimally
these signals (Figures 3A and 4B).
The characterization of the cellular sources of oxidative stress
has indicated that the CBDL-induced increased DHE fluorescence
signal was markedly reduced by apocynin (an NADPH oxidase
inhibitor and antioxidant), L-NA (an eNOS inhibitor), sulfaphe-
nazol (a cytochrome P450 inhibitor), indomethacin (a cyclooxy-
genase inhibitor) and by a combination of inhibitors of the
mitochondrial respiration chain (KCN, myxothiazol and rotenone)
suggesting the involvement of NADPH oxidase, COXs, uncoupled
eNOS, cytochrome P450, and the mitochondrial respiration chain
(Figure 3C).
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To obtain further evidence for a role of NADPH oxidase and
COXs, their expression level was determined by immunofluores-
cence staining and Western blot analysis in the aorta. A
significantly increased immunofluorescence signal of the NAPDH
oxidase subunits p22phox and p47phox, and of COX-1 and
COX-2 was observed in the aorta of the CBDL group compared
to the sham group (Figure 4A). The VSL#3 treatment signifi-
cantly reduced the CBDL-induced stimulatory effect for p22phox,
p47phox and COX-2 whereas that for COX-1 was minimally
affected (Figure 4A). The VSL#3 treatment of sham rats affected
minimally all these signals (Figure 4A). In addition, an upregula-
tion of p22phox and p47phox protein levels was also observed in
the CBDL group as assessed by Western blot analysis whereas no
such effect was observed in the CBDL+VSL#3 group (Figure 4B).
In contrast, COX-2 protein levels were similar in all groups, and
COX-1 protein levels were below the detection level (Figure 4B).
Table 1. Effect of VSL#3 ingestion on body, liver and spleen weight in both sham and CBDL rats.
Initial body weight (g) Final body weight (g) Liver (% total weight) Spleen (% total weight)
Sham 365619.5 505630.2 3.2460.06 0.2060.02
Sham+VSL#3 368614.3 506626.4 3.3360.18 0.2360.02
CBDL 369616.3 485630.5 6.6960.63* 0.6960.05*
CBDL+VSL#3 365615.7 507647.6 6.0260.55 0.5660.09#
Values are shown as mean 6 SEM of 6 rats. *P,0.05 CBDL vs sham, and #P,0.05 for CBDL+VSL#3 vs CBDL.
doi:10.1371/journal.pone.0097458.t001
Figure 1. Ingestion of VSL#3 improves the CBDL-induced blunted EDH but not NO-mediated relaxations in mesenteric artery
rings. Concentration-relaxation curves to acetylcholine in mesenteric artery rings with endothelium in sham, CBDL, sham+VSL#3 and CBDL+VSL#3
rats. A) The NO component of the relaxation was assessed in the presence of indomethacin (10 mM) and apamin plus charybdotoxin (100 nM each),
and B) the EDH component in the presence of indomethacin and NG-nitro-L-arginine (300 mM). C) Relaxations to sodium nitroprusside (an exogenous
donor of NO) and D) levcromakalim (an ATP-sensitive K+ channel opener) in mesenteric artery rings without endothelium are also shown. Results are
shown as mean6SEM of 5-7 different rats; *P,0.05 CBDL vs sham, and #P,0.05 CBDL+VSL#3 vs CBDL.
doi:10.1371/journal.pone.0097458.g001
Probiotics Improves Endothelial Dysfunction
PLOS ONE | www.plosone.org 4 May 2014 | Volume 9 | Issue 5 | e97458
VSL#3 treatment improves the CBDL-induced expression
of the local angiotensin system
An increased immunofluorescence level of angiotensin II, AT1
receptors and ACE throughout the aortic wall was observed in the
CBDL group (Figure 5). The stimulatory effect of CBDL was
significantly prevented by the VSL#3 treatment (Figure 5). The
VSL#3 treatment alone affected minimally all these signals
(Figure 5). An upregulation of the AT1 receptor protein level was
also observed in the CBDL group by Western blot analysis
whereas no such effect was observed in the CBDL+VSL#3 group
(Figure 4B).
VSL#3 treatment prevents the CBDL-induced increase in
plasma pro-inflammatory cytokines
A significant increase in the plasma level of pro-inflammatory
cytokines including IL-1a, MCP-1 and TNF-a was observed in the
CBDL group, and this effect was significantly prevented by the
VSL#3 treatment (Figure 6). In contrast, the plasma level of IL-4,
which is a potent anti-inflammatory cytokine, was markedly
reduced in the CBDL group, and this effect was significantly
prevented by the VSL#3 treatment (Figure 6). The VSL#3
treatment of sham rats affected minimally all these cytokines
(Figure 6).
Discussion
The present study indicates that the CBDL-induced endothelial
dysfunction involves predominantly a reduced EDH component
and, also, to some extent a decreased NO component in the
mesenteric artery. The blunted EDH component is associated with
a reduced expression of SKCa and IKCa levels, and Cx30, Cx37
and Cx40 levels, which are all involved in the EDH response, most
likely as a consequence of the activation of the local angiotensin
system leading to an increased vascular oxidative stress, and the
formation of pro-inflammatory mediators. They further indicate
that ingestion of the probiotic VSL#3 formulation effectively
prevented the CBDL-induced endothelial dysfunction, at least in
part, by targeting the vascular angiotensin system.
Biliary cirrhosis induced by chonic bile duct ligation in rats and
evidenced by an increased spleen weight and enhanced bile duct
proliferation is associated with an unaffected acetylcholine-
induced endothelium-dependent relaxation in mesenteric artery
rings. In contrast, when experiments were performed to study
selectively either the NO component or the EDH component then
a significant reduction of both components was observed in the
CBDL group as observed previously in some but not all studies
[11],[22],[23]. A severely reduced EDH component despite an
unaffected ACh-induced relaxation has also been observed
previously in aging-related endothelial dysfunction [24]. Such a
difference is most likely explained by the fact that the NO
component and the EDH component, although blunted, act in
synergy to maintain a normal endothelium-dependent relaxation
whereas such a compensating mechanism cannot take place when
a single component is evaluated. Alternatively, the present findings
due not rule out the possibility that vasoactive prostanoids
contribute to preserve the acetylcholine-induced endothelium-
dependent relaxation in the CBDL group. However, previous
findings have indicated that although prostacyclin evoked relax-
ations in mesenteric resistance arteries from control rats, the
prostanoid induced also contractile responses in arteries from
spontaneously hypertensive rats presenting an endothelial dys-
function [25]. Moreover, chronic COX inhibition did not affect
Figure 2. The VSL#3 treatment prevents the CBDL-induced A) up-regulation eNOS and down-regulation of SKca and IKca, and B)
down-regulation of connexins (Cx37, Cx40 and Cx43) in the mesenteric artery. Upper panels show representative immunofluorescence
staining, and lower panels corresponding cumulative data. C) Expression of eNOS and SKCa protein levels as assessed by Western blot analysis. Results
are shown as mean6SEM of 4 different rats for A and B, and 3 for C. *P,0.05 for CBDL vs sham, and #P,0.05 CBDL+VSL#3 vs CBDL.
doi:10.1371/journal.pone.0097458.g002
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Figure 3. The VSL#3 treatment prevents the CBDL-induced oxidative stress in the aorta. (A) In situ determination of the formation of
ROS, peroxynitrite (nitrotyrosine), and eNOS in aortic sections. Top: representative immunofluorescence staining; bottom: corresponding cumulative
data for 4 to 5 rats/group. (B) To study the cellular sources of ROS, aortic sections were exposed either to apocynin (NADPH oxidase inhibitor and
Probiotics Improves Endothelial Dysfunction
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antioxidant), L-NA (NO synthase inhibitor), sulfaphenazol (Sulfa, cytochrome P450 inhibitor), indomethacin (Indo, cyclooxygenase inhibitor) or the
combination KCN, myxothiazol and rotenone (KCN+MY+Rot, inhibitors of the mitochondrial respiration chain) for 30 min before DHE staining. Top of
each panel: DHE staining; bottom: corresponding cumulative data for 4 rats. Results are shown as mean6SEM. The lumen is on the right side of each
image. A) *P,0.05 CBDL vs sham, and #P,0.05 CBDL+VSL#3 vs CBDL; B) *P,0.05 versus control.
doi:10.1371/journal.pone.0097458.g003
Figure 4. The VSL#3 treatment prevents the CBDL-induced up-regulation of the NAPDH oxidase subunits p22phox and p47phox,
and COX-2 but not COX-1 in aortic sections. A) Representative immunofluorescence staining and corresponding cumulative data. B) Expression
levels of target proteins as assessed by Western blot analysis in aortic segments. Results are shown as mean6SEM of 4 different rats. *P,0.05 CBDL vs
sham, and #P,0.05 CBDL+VSL# 3 vs CBDL.
doi:10.1371/journal.pone.0097458.g004
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the CBDL-induced decrease in mean arterial pressure in CBDL
rats [26].
The impaired EDH-mediated relaxation is most likely the
consequence of the decreased expression in IKCa and SKCa
involved in EDH formation, and also of Cx37, Cx40 and Cx43,
which form myoendothelial gap junctions transmitting the
endothelial hyperpolarization towards the underlying smooth
muscle [11]. In addition to the present findings, oxidative stress
has been suggested to contribute to the impaired EDH-mediated
relaxation [11]. The present findings further extent these previous
observations by showing that oxidative stress is generated by
several sources including NADPH oxidase, uncoupled eNOS,
cytochome P450, COXs and the mitochondrial respiration chain.
Moreover, an upregulation of several pro-oxidant enzymes
including NADPH oxidase, COX-1, and COX-2 is observed in
the arterial wall of CBDL rats. Besides the EDH component, the
NO component of the relaxation is also impaired in CBDL rats
despite an increased expression of eNOS. This latter response is
most likely part of a compensatory mechanism due to the
degradation of the excessive formation of NO by superoxide
anions as indicated by the increased peroxynitrite level.
The present findings support a key role for the angiotensin
system in the CBDL-induced endothelial dysfunction. Indeed, an
increased expression of ACE, Ang II and AT1R was observed
throughout the arterial wall of CBDL rats. They are also consistent
with the fact that losartan, an AT1 receptor antagonist, prevented
the CBDL-induced endothelial dysfunction and oxidative stress
[11]. A major novel finding of the present study is that ingestion of
the probiotic VSL#3 formulation improved the endothelial
dysfunction in CBDL rats along with a pronounced improvement
of the local angiotensin system and the level of oxidative stress in
the arterial wall.
Previous studies have shown that amongst factors involved in
the general vasodilatation in cirrhosis is bacterial translocation
[3,5,12]. Indeed, an alteration of the gut microflora associated
with disruption of the gut mucosal barrier leading to bacterial
translocation has been observed in 45–75% of animals with
experimental cirrhosis [14,15]. This response, in turn, promotes
the subsequent inflammatory response, which will contribute to
the hyperdynamic circulatory state in cirrhosis [5,12,16]. Indeed,
treatments preventing bacterial translocation using either anti-
obiotics or pentoxifylline (an inhibitor of TNF- a) reduced the
excessive vasodilatation in CBDL rats [5,12,16]. However, the
long-term use of antibiotics and pentoxifylline is hazardous due to
the risk of inducing bacterial resistance with antibiotics and the
poor tolerance of pentoxifylline as reported in a pilot study by
Tanikella et al. [18]. In contrast, chronic use of probiotics has not
been associated with major side effects [19,20]. Furthermore,
previous studies have indicated that intake of probiotics such as the
VSL#3 formulation leads to major changes in the composition of
the gut flora in both experimental animals and in humans. Indeed,
intake of VSL#3 in patients with pouchitis was associated with an
increased intestinal bacterial diversity and a reduced fungal
diversity in comparison with patients treated with a placebo
[27]. VSL#3 treatment also prevented the antibiotic-induced
decrease in several indigenous bacterial groups as assessed using a
standardized human fecal microbiota in a computer-controlled
model of large intestine [28]. Moreover, intake of the VSL#3
formulation in rats altered the species richness and diversity of the
luminal intestinal microbiota [29]. However, the possibility that
the beneficial effect of the VSL#3 treatment on the CBDL-
induced endothelial dysfunction involves an improved bacterial
translocation still remains to be determined.
The study of Loguercio et al. [20] indicated that administration
of VSL#3 to alcoholic liver cirrhosis patients led to an
improvement of the liver function and the increased plasma level
of oxidative stress and TNF-a. In the present study, a relatively
small but significant improvement of spleen weights was observed
suggesting that VSL#3 may also have some effects on cirrhosis in
CBDL rats, which, however, cannot account solely for the
improved endothelial function.
In addition in a rat model of cirrhosis induced by CCl4, Chiva
et al. [30] reported that the addition of Lactobacillus johnsonii to an
antioxidant treatment (vitamin C plus glutamate) reduced
endotoxemia possibly due to an increased clearance of endotoxins
by the monocyte-macrophage system. The VSL#3 treatment also
Figure 5. The VSL#3 treatment prevents the CBDL-induced up-
regulation of several components of the local angiotensin
system in the aorta. The expression level of angiotensin II (Ang II),
AT1 receptors (AT1R) and angiotensin-converting enzyme (ACE) was
determined by immunofluorescence staining. Upper panels show
representative immunofluorescence staining; Lower panels correspond-
ing cumulative data. Results are shown as mean6SEM of 4 different
rats. *P,0.05 CBDL vs sham, and #P,0.05 CBDL+VSL#3 vs CBDL.
doi:10.1371/journal.pone.0097458.g005
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reduced the CBDL-induced pro-inflammatory response as indi-
cated by the improvement of circulating levels of pro-inflamma-
tory cytokines such as IL-1a and TNF-a. Thus, the protective
effect of VSL#3 in CBDL rats may involve, besides an
improvement of the gut flora composition, possibly also the
stimulation of immunological defence mechanisms and perhaps
also the recovery of the intestinal motility, which has been shown
to be decreased in cirrhosis with bacterial translocation [31].
Another potential protective mechanism of VSL#3 is that upon
fermentation, various probiotics (including those contained in
VSL#3, [32]) are capable of releasing ACE inhibitory peptides.
This has been observed in vitro [32,33] and also in vivo in
hypertensive rats [34] and patients [35]. In an in vivo trial, the
ingestion of milk fermented with probiotics led to a significant
decrease in blood pressure [35]. In the present study, a normalized
vascular expression level of ACE, angiotensin II and AT1R along
with a reduced expression of NADPH oxidase was observed in
CBDL rats treated with VSL#3. Since infusion of angiotensin II
leads to an increased vascular expression of NADPH oxidase and
oxidative stress [36], it is likely that the VSL#3 treatment may
improve oxidative stress by reducing the local angiotensin system
subsequent to the normalization of ACE expression. Alternatively,
VSL#3 may also normalize ACE activity via the release of ACE
inhibitory peptides as suggested by previous studies [32,35].
In conclusion, the present findings indicate that oxidative stress
possibly due to bacterial translocation inducing a pro-inflamma-
tory response and the local angiotensin system is involved in the
endothelial dysfunction in CBDL rats, and that this effect is
improved by the ingestion of the probiotic VSL#3 formulation.
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